530207 — Brawn Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Brawn Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15.7	15.2	14	15.6
Net Total Accounts Receivable
Net Total Receivables	53.3	39	34.3	35.6
Total Inventory
Total Other Current Assets
Total Current Assets	134	131	175	171
Net Property, Plant And Equipment	3.72	3.33	4.6	3.65
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	145	146	205	209
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	80.5	65.1	93.3	152
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	82.2	95.2	171	165
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	63.1	50.7	33.6	43.4
Total Liabilities & Shareholders' Equity	145	146	205	209
Total Common Shares Outstanding